Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Pain Management Market by Type (Pharmaceuticals, Devices), By Application (Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Pain Management Market by Type (Pharmaceuticals, Devices), By Application (Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 137584 3300 Pharma & Healthcare 377 231 Pages 4.9 (32)
                                          

The global pain management market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic pain, rising geriatric population, and growing awareness about the benefits of pain management. Pharmaceuticals segment accounted for the largest share in the global pain management market in 2018 and is expected to continue its dominance throughout the forecast period. The pharmaceuticals segment includes drugs that are used for treating acute or chronic pain conditions such as opioids, non-steroidal anti-inflammatory drugs (NSAIDs), antidepressants, anticonvulsants, and others. These drugs are prescribed by physicians based on their efficacy and side effects profile. North America dominated the global pharmaceuticals segment in 2018 with a share of over 40%. This can be attributed to high prevalence rates of chronic diseases such as cancer and diabetes among adults in North America which leads to increased incidence rates of various types of pains including neuropathic pains which require long-term treatment with analgesics or other medications that have been approved by regulatory authorities for this purpose.

Some Of The Growth Factors Of This Market:

  1. The aging population is a major factor in the growth of the pain management market.
  2. The increase in chronic pain cases is also a major factor in the growth of the pain management market.
  3. The increasing number of people suffering from chronic diseases such as cancer, diabetes, and arthritis are also factors that contribute to the growth of this market.
  4. Increasing awareness about pain management and its benefits among patients is another factor that contributes to this market's growth.
  5. Increasing research on new drugs for treating chronic conditions such as cancer, diabetes, and arthritis will also contribute to this market's growth.

Industry Growth Insights published a new data on “Pain Management Market”. The research report is titled “Pain Management Market research by Types (Pharmaceuticals, Devices), By Applications (Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain), By Players/Companies Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic Inc., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, St. Jude Medical Inc.”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Pain Management Market Research Report

By Type

Pharmaceuticals, Devices

By Application

Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain

By Companies

Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic Inc., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, St. Jude Medical Inc.

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

231

Number of Tables & Figures

162

Customization Available

Yes, the report can be customized as per your need.


Global Pain Management Industry Outlook


Global Pain Management Market Report Segments:

The global Pain Management market is segmented on the basis of:

Types

Pharmaceuticals, Devices

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbvie Inc.
  2. Astrazeneca Depomed Inc.
  3. Djo Global Inc.
  4. Eli Lilly & Co.
  5. Endo International
  6. Glaxosmithkline
  7. Hisamitsu Pharmaceutical Co. Inc.
  8. Johnson & Johnson
  9. Medtronic Inc.
  10. Novartis International Ag
  11. Pfizer
  12. Purdue Pharmaceuticals Lp
  13. St. Jude Medical Inc.

Global Pain Management Market Overview


Highlights of The Pain Management Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Pharmaceuticals
    2. Devices
  1. By Application:

    1. Burn Pain
    2. Cancer Pain
    3. Dental/Facial Pain
    4. Migraine Headache Pain
    5. Musculoskeletal Pain
    6. Neuropathic Pain
    7. Obstetrical Pain
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Pain Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Pain Management Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Pain management is the process of managing pain in a person. Pain can be physical, emotional, or both. Pain management may include treatments such as medication, surgery, and physical therapy.

Some of the key players operating in the pain management market are Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic Inc., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, St. Jude Medical Inc..

The pain management market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Pain Management Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Pain Management Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Pain Management Market - Supply Chain
   4.5. Global Pain Management Market Forecast
      4.5.1. Pain Management Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Pain Management Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Pain Management Market Absolute $ Opportunity

5. Global Pain Management Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Pain Management Market Size and Volume Forecast by Type
      5.3.1. Pharmaceuticals
      5.3.2. Devices
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Pain Management Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Pain Management Market Size and Volume Forecast by Application
      6.3.1. Burn Pain
      6.3.2. Cancer Pain
      6.3.3. Dental/Facial Pain
      6.3.4. Migraine Headache Pain
      6.3.5. Musculoskeletal Pain
      6.3.6. Neuropathic Pain
      6.3.7. Obstetrical Pain
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Pain Management Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Pain Management Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Pain Management Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Pain Management Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Pain Management Demand Share Forecast, 2019-2029

9. North America Pain Management Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Pain Management Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Pain Management Market Size and Volume Forecast by Application
      9.4.1. Burn Pain
      9.4.2. Cancer Pain
      9.4.3. Dental/Facial Pain
      9.4.4. Migraine Headache Pain
      9.4.5. Musculoskeletal Pain
      9.4.6. Neuropathic Pain
      9.4.7. Obstetrical Pain
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Pain Management Market Size and Volume Forecast by Type
      9.7.1. Pharmaceuticals
      9.7.2. Devices
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Pain Management Demand Share Forecast, 2019-2029

10. Latin America Pain Management Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Pain Management Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Pain Management Market Size and Volume Forecast by Application
      10.4.1. Burn Pain
      10.4.2. Cancer Pain
      10.4.3. Dental/Facial Pain
      10.4.4. Migraine Headache Pain
      10.4.5. Musculoskeletal Pain
      10.4.6. Neuropathic Pain
      10.4.7. Obstetrical Pain
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Pain Management Market Size and Volume Forecast by Type
      10.7.1. Pharmaceuticals
      10.7.2. Devices
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Pain Management Demand Share Forecast, 2019-2029

11. Europe Pain Management Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Pain Management Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Pain Management Market Size and Volume Forecast by Application
      11.4.1. Burn Pain
      11.4.2. Cancer Pain
      11.4.3. Dental/Facial Pain
      11.4.4. Migraine Headache Pain
      11.4.5. Musculoskeletal Pain
      11.4.6. Neuropathic Pain
      11.4.7. Obstetrical Pain
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Pain Management Market Size and Volume Forecast by Type
      11.7.1. Pharmaceuticals
      11.7.2. Devices
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Yo-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Pain Management Demand Share, 2019-2029

12. Asia Pacific Pain Management Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Pain Management Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Pain Management Market Size and Volume Forecast by Application
      12.4.1. Burn Pain
      12.4.2. Cancer Pain
      12.4.3. Dental/Facial Pain
      12.4.4. Migraine Headache Pain
      12.4.5. Musculoskeletal Pain
      12.4.6. Neuropathic Pain
      12.4.7. Obstetrical Pain
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Pain Management Market Size and Volume Forecast by Type
      12.7.1. Pharmaceuticals
      12.7.2. Devices
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Pain Management Demand Share, 2019-2029

13. Middle East & Africa Pain Management Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Pain Management Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Pain Management Market Size and Volume Forecast by Application
      13.4.1. Burn Pain
      13.4.2. Cancer Pain
      13.4.3. Dental/Facial Pain
      13.4.4. Migraine Headache Pain
      13.4.5. Musculoskeletal Pain
      13.4.6. Neuropathic Pain
      13.4.7. Obstetrical Pain
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Pain Management Market Size and Volume Forecast by Type
      13.7.1. Pharmaceuticals
      13.7.2. Devices
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Pain Management Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Pain Management Market: Market Share Analysis
   14.2. Pain Management Distributors and Customers
   14.3. Pain Management Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Abbvie Inc.
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Astrazeneca Depomed Inc.
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Djo Global Inc.
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Eli Lilly & Co.
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Endo International
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Glaxosmithkline
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Hisamitsu Pharmaceutical Co. Inc.
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Johnson & Johnson
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Medtronic Inc.
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Novartis International Ag
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Pfizer
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Purdue Pharmaceuticals Lp
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. St. Jude Medical Inc.
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us